IRIS
CAGNACCI, ANGELO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 11.391
Totale 11.391
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 11.391
Totale 11.391
Salva come PNG Salva come JPEG
Città #
Genova 8.034
Vado Ligure 1.268
Genoa 1.171
Rapallo 834
Bordighera 84
Totale 11.391
Salva come PNG Salva come JPEG
Nome #
Maternal age and the risk of adverse pregnancy outcomes: a retrospective cohort study 119
Acupuncture or phy(F)itoestrogens vs. (E)strogen plus progestin on menopausal symptoms. A randomized study 109
Age at Menopause and Extent of Coronary Artery Disease Among Postmenopausal Women with Acute Coronary Syndromes 103
Progestin suppressed inflammation and cell viability of tumor necrosis factor-α-stimulated endometriotic stromal cells 100
Prospective measurement of blood pressure and heart rate over 24 h in women using combined oral contraceptives with estradiol 96
Attitudes and perceptions towards vulvar and vaginal atrophy in Italian post-menopausal women: Evidence from the European REVIVE survey 95
Diagnosis and management of symptoms associated with vulvovaginal atrophy: expert opinion on behalf of the Italian VVA study group (.) 93
Bleeding profile in users of an etonogestrel sub-dermal implant: Effects of anthropometric variables. An observational uncontrolled preliminary study in Italian population 92
Impact of vulvovaginal atrophy of menopause: prevalence and symptoms in Italian women according to the EVES study 92
Association between urinary incontinence and climacteric symptoms in postmenopausal women 92
Recommendations for contraception in women with diabetes. AMD-SIC position paper 92
Age at menopause, extent of coronary artery disease and outcome among postmenopausal women with acute coronary syndromes 92
Adenomyosis of the Extrapelvic Portion of the Round Ligament 91
Does dienogest influence the inflammatory response of endometriotic cells? A systematic review 90
Administration of raloxifene does not influence 24-hour ambulatory blood pressure of postmenopausal women with osteopenia: a double-blind placebo-controlled study 90
Body composition and resting metabolic rate of perimenopausal women using continuous progestogen contraception 89
Association between pelvic organ prolapse and climacteric symptoms in postmenopausal women 88
Oral contraceptives and insulin sensitivity 88
Hormone replacement therapy and prevention of chronic conditions 87
Intermenstrual pelvic pain, quality of life and mood 86
Venous thrombosis and hormonal contraception: what's new with estradiol-based hormonal contraceptives? 85
Integrated Clinical Pathways in vaginal and caesarean delivery: effect analysis 2016-2017, Italy 85
Are climacteric complaints associated with risk factors of cardiovascular disease in peri-menopausal women? 85
Monurelle Biogel® vaginal gel in the treatment of vaginal dryness in postmenopausal women 85
The relation of season of birth to severity of menopausal symptoms 85
The Association between Endometriomas and Ovarian Cancer: Preventive Effect of Inhibiting Ovulation and Menstruation during Reproductive Life 84
Pharmacokinetic evaluation of desogestrel as a female contraceptive 84
Seasonal trend of acute pelvic inflammatory disease 83
Administration of tibolone decreases 24h heart rate but not blood pressure of post-menopausal women 83
Dienogest mediates midkine suppression in endometriosis 83
Route of administration of contraceptives containing desogestrel/etonorgestrel and insulin sensitivity: a prospective randomized study 82
Relation between oxidative stress and climacteric symptoms in early postmenopausal women 82
Relationship between urinary estrogen levels before conception and sex ratio at birth in a primate, the gray mouse lemur 81
Modification of body composition and metabolism during oral contraceptives containing non-androgenic progestins in association with estradiol or ethinyl estradiol 81
Medical and patient attitude towards vaginal atrophy: the AGATA study 81
Management of vaginal atrophy: a real mess. Results from the AGATA study 80
Cyclic progestin administration increases energy expenditure and decreases body fat mass in perimenopausal women 80
The most bothersome symptom of vaginal atrophy: Evidence from the observational AGATA study 80
Folate administration decreases oxidative status and blood pressure in postmenopausal women 80
Kava-Kava administration reduces anxiety in perimenopausal women 80
High-dose short-term folate administration modifies ambulatory blood pressure in postmenopausal women. A placebo-controlled study 79
ISPOG European Consensus Statement - chronic pelvic pain in women (short version) 79
Prediction of age at menopause from assessment of ovarian reserve may be improved by using body mass index and smoking status 79
Insulin sensitivity and lipid metabolism with oral contraceptives containing chlormadinone acetate or desogestrel: a randomized trial 78
Modification of blood pressure in postmenopausal women: role of hormone replacement therapy 78
Treatment continuation and satisfaction in women using combined oral contraception with nomegestrol acetate and oestradiol: a multicentre, prospective cohort study (BOLERO) 78
Vasomotor symptoms and management of women undergoing treatment for breast cancer: literature review with focus on the therapeutic potential of cytoplasmic pollen extract 77
Comparison of the effect of oral and transdermal hormone therapy on fasting and postmethionine homocysteine levels 76
Relation of homocysteine, folate, and vitamin B12 to bone mineral density of postmenopausal women 76
“In patient” medical abortion versus surgical abortion: patient’s satisfaction 76
European society of contraception statement on contraception in obese women 76
Vasomotor symptoms in menopause: a biomarker of cardiovascular disease risk and other chronic diseases? 76
Combined Hormonal Contraceptive Use and Risk of Breast Cancer in a Population of Women With a Family History 76
Role of close endocervical margin in treatment failure after cervical excision for cervical intraepithelial neoplasia: A retrospective study 76
Sexual dimorphism in the levels of amniotic fluid leptin in pregnancies at 16 weeks of gestation 75
Vaginal atrophy across the menopausal age: results from the ANGEL study 75
Contraception in cancer survivors–an expert review Part II. Skin, gastrointestinal, haematological and endocrine cancers 75
Influences of maternal weight on the secondary sex ratio of human offspring 74
A comparison of the central effects of different progestins used in hormone replacement therapy 74
Small fetal thymus and adverse obstetrical outcome: a systematic review and a meta-analysis 74
Role of a natural integrator based on lipoic acid, palmitoiletanolamide and myrrh in the treatment of chronic pelvic pain and endometriosis 74
Counseling on vaginal delivery of contraceptive hormones: implications for women's body knowledge and sexual health 73
Impact of laparoscopic cystectomy of endometriotic and non-endometriotic cysts on ovarian volume, antral follicle count (AFC) and ovarian doppler velocimetry 73
Impact of transvaginal hydrolaparoscopy ovarian drilling on ovarian stromal blood flow and ovarian volume in clomiphene citrate-resistant PCOS patients: a case-control study 73
Role of melatonin in circadian rhythm at menopause 73
The Controversial History of Hormone Replacement Therapy 73
Glucose metabolism and insulin resistance in women with polycystic ovary syndrome during therapy with oral contraceptives containing cyproterone acetate or desogestrel 72
Levonorgestrel administration in emergency contraception: bleeding pattern and pituitary-ovarian function 72
Hereditary Ovarian Cancer: Not Only BRCA 1 and 2 Genes 72
Influence of an oral contraceptive containing drospirenone on insulin sensitivity of healthy women 72
Evaluation of Transvaginal Ultrasound plus CA-125 Measurement and Prophylactic Salpingo-Oophorectomy in Women at Different Risk Levels of Ovarian Cancer: The Modena Study Group Cohort Study 72
Menopausal symptoms and risk factors for cardiovascular disease in postmenopause 72
Prolonged melatonin administration decreases nocturnal blood pressure in women 71
History of vasomotor symptoms, extent of coronary artery disease, and clinical outcomes after acute coronary syndrome in postmenopausal women 71
Raloxifene does not influence flow-mediated endothelium-dependent and endothelium-independent vasodilatation of osteopenic postmenopausal women 71
Seasonal onset of the menopause 71
Endothelin-1 and nitric oxide levels are related to cardiovascular risk factors but are not modified by estradiol replacement in healthy postmenopausal women. A cross-sectional and a randomized cross-over study 71
Clinical effect of hormonal replacement therapy with estradiol associated with noretisterone or drospirenone. A prospective randomized placebo controlled study 71
Relation between body mass index and endothelium-dependent vasodilatation in healthy postmenopausal women 71
Inflammation influences steroid hormone receptors targeted by progestins in endometrial stromal cells from women with endometriosis 71
Hormonal contraception: venous and arterial disease 71
null 71
Massive Hemoperitoneum from Uterine Leiomyoma Associated with Diffuse Myometrial Venous Congestion 70
Macro-regional variation in attitudes toward and experiences of vulvar and vaginal atrophy among Italian post-menopausal women: a post hoc analysis of REVIVE survey data 70
The impact of reproductive life on breast cancer risk in women with family history or BRCA mutation 70
Neutral effect of prolonged transdermal hormone therapy on liver function of postmenopausal women with chronic active hepatitis 70
Chronic pelvic pain improvement: impact on quality of life and mood 69
Effects of progestins on estrogen-induced increase in C-reactive protein in postmenopausal women 69
Metabolic impact of combined hormonal contraceptives containing estradiol 69
Asymptomatic SARS-CoV-2 infections in pregnant patients in an Italian city during the complete lockdown 69
Modification of 24-h ambulatory blood pressure and heart rate during contraception with the vaginal ring: a prospective study 68
Season of birth influences the timing of menopause 68
The male disadvantage and the seasonal rhythm of sex ratio at the time of conception 68
Histological evaluation of the prevalence of adenomyosis, myomas and of their concomitance 67
Menopause, estrogens, progestins, or their combination on body weight and anthropometric measures 67
Prevalence of menstrual pain in young women: what is dysmenorrhea 67
Vaginal atrophy of women in postmenopause. Results from amulticentric observational study: The AGATA study 66
Pelvic Pain and Quality of Life of Women With Endometriosis During Quadriphasic Estradiol Valerate/Dienogest Oral Contraceptive. A Patient-Preference Prospective 24-Week Pilot Study 66
Effect of oral contraceptives containing estradiol and nomegestrol acetate or ethinyl-estradiol and chlormadinone acetate on primary dysmenorrhea 66
Effects of low- or high-dose hormone therapy on fasting and post-methionine homocysteine levels in postmenopausal women 66
Totale 7.866
Salva come PNG Salva come JPEG
Categoria #
all - tutte 50.610
article - articoli 49.835
book - libri 0
conference - conferenze 296
curatela - curatele 0
other - altro 255
patent - brevetti 0
selected - selezionate 0
volume - volumi 224
Totale 101.220
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.373 0 0 0 0 0 0 1.039 605 514 647 463 105
2020/20211.736 104 265 143 171 64 97 101 206 114 248 124 99
2021/20221.751 91 38 46 163 33 221 27 429 242 113 104 244
2022/20231.269 213 64 5 83 126 134 14 79 216 12 289 34
2023/2024823 44 120 26 92 68 35 35 92 29 32 66 184
2024/20251.417 67 319 71 92 521 327 20 0 0 0 0 0
Totale 11.907